人参皂苷CK药物递送系统研究进展OA
Research Advances in Drug Delivery Systems of Ginsenoside CK
人参皂苷CK(ginsenoside compound K,CK)虽具药理潜力,但需通过制剂技术转化为实用剂型以提升疗效、降低毒副作用,促进其从活性成分向临床应用转化.随着药剂学发展,新剂型推动CK制剂研究不断深入.该文按照递送系统进行分类,系统综述了CK在被动靶向、主动靶向、理化性质响应型及非靶向递送系统中的研究现状,剖析了当前研究存在的问题,为CK制剂的开发与临床应用提供了新思路和参考依据.
Although ginsenoside CK(CK)has pharmacological potential,it needs to be transformed into practical dosage forms via pharmaceutical formulation technology to improve efficacy,reduce toxic and side effects,and promote its translation from active ingredient to clinical application.With the development of pharmaceutics,novel dosage forms have driven further advances in the research of CK formulations.This paper systematically reviews the research status of CK in passive targeting,active targeting,physicochemical property-responsive and non-targeted delivery systems by classifying according to delivery systems,analyzes the existing problems in current research,and provides new ideas and references for the development and clinical application of CK formulations.
吕俊晓;冀帅延;闻波伟;赵丽艳
河北北方学院药学院,河北省神经药理学重点实验室,张家口,075000,中国河北北方学院药学院,河北省神经药理学重点实验室,张家口,075000,中国河北北方学院药学院,河北省神经药理学重点实验室,张家口,075000,中国河北北方学院药学院,河北省神经药理学重点实验室,张家口,075000,中国
医药卫生
人参皂苷CK靶向制剂偶联物研究进展药物递送系统
ginsenoside CKtargeted delivery systemsconjugatereviewdrug delivery system
《神经药理学报》 2026 (1)
34-50,17
河北省属高校基本科研业务计划项目(No.JYT2025007 和JYT2020002),大学生创新训练计划项目(No.S202210092005),河北北方学院校级项目(No.BSJJ202211),青年研究生导师资助项目(No.DSZZ202510)
评论